Actavis has received a preliminary approval for a generic drug for treating high blood pressure, the drug maker said Thursday.
The Food and Drug Administration has approved a new use for a Shire drug to treat attention deficit hyperactivity disorder, Shire said Monday.
Drug maker Shire has filed a patent infringement suit against Watson Pharmaceuticals and Impax Labs in response to their attempt to win approval from the Food and Drug Administration for a generic version of a Shire drug.
British drug maker Shire presented late-stage clinical study data at a psychiatric meeting Friday indicating...
British drug maker Shire will present data on two attention deficit hyperactivity disorder treatments in...
Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...